Results
|
|
3421.
|
|
|
|
3422.
|
|
|
|
3423.
|
|
|
|
3424.
|
|
|
|
3425.
|
|
|
|
3426.
|
|
|
|
3427.
|
|
|
|
3428.
|
|
|
|
3429.
|
|
|
|
3430.
|
|
|
|
3431.
|
|
|
|
3432.
|
|
|
|
3433.
|
|
|
|
3434.
|
|
|
|
3435.
|
|
|
|
3436.
|
|
|
|
3437.
|
|
|
|
3438.
|
Phase I safety and pharmacokinetics of BAY 43-9006 administered for 21 days on/7 days off in patients with advanced, refractory solid tumours. [electronic resource] by
- Awada, A
- Hendlisz, A
- Gil, T
- Bartholomeus, S
- Mano, M
- de Valeriola, D
- Strumberg, D
- Brendel, E
- Haase, C G
- Schwartz, B
- Piccart, M
Producer: 20050616
In:
British journal of cancer vol. 92
Availability: No items available.
|
|
|
3439.
|
|
|
|
3440.
|
|